These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23974124)

  • 1. Pharmacy compounding urban legends.
    Kastango ES
    Int J Pharm Compd; 2006; 10():32-4. PubMed ID: 23974124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 18: verification of automated compounding devices for parenteral nutrition compounding and finished preparation release checks and tests.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2010; 14(2):142-9. PubMed ID: 23965426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basics of compounding: United States pharmacapeia general chapter 797 pharmaceutical compounding-sterile preparations, part 10: first revision: the main changes, events, and rationale.
    Okeke CC; Newton DW; Kastango ES; Allen LV
    Int J Pharm Compd; 2008; 12(6):530-6. PubMed ID: 23969931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applying Quality by Design Concepts to Pharmacy Compounding.
    Timko RJ
    Int J Pharm Compd; 2015; 19(6):453-63. PubMed ID: 26891559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basics of compounding: implementing United States pharmacopeia chapter <795> pharmaceutical compounding--nonsterile preparations, part 4.
    Allen LV
    Int J Pharm Compd; 2012; 16(1):64-8. PubMed ID: 23050315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 20: patient or caregiver training, patient monitoring and adverse events reporting, and quality-assurance program.
    Okeke CC; Allen LV
    Int J Pharm Compd; 2010; 14(4):328-31. PubMed ID: 23965541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations.
    Okeke CC; Allen LV
    Int J Pharm Compd; 2010; 14(1):60-4. PubMed ID: 23965372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sterile Compounding Pharmacies: States That Do and Do Not Require Compliance With USP <797> Versus FDA 483s.
    Wilson M
    Ther Innov Regul Sci; 2016 May; 50(3):279-303. PubMed ID: 30227076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 14: environmental quality and control (continued).
    Okeke CC; Allen LV
    Int J Pharm Compd; 2009; 13(4):322-9. PubMed ID: 23966523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing United States Pharmacopeia chapter <1163> quality assurance in pharmaceutical compounding, Part 1.
    Allen LV
    Int J Pharm Compd; 2012; 16(2):146-9. PubMed ID: 23050327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 4: considerations in selection and use of disinfectants and antiseptics.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2007; 11(6):492-9. PubMed ID: 23994811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basics of compounding: application of the United States pharmacopeia bacterial endotoxins test to compounded sterile preparations.
    Dawson MF
    Int J Pharm Compd; 2006; 10():36-9. PubMed ID: 23974125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of United States pharmacopeia chapter 795 and american society of health-system pharmacists guidelines for nonsterile compounding.
    McElhiney LF
    Int J Pharm Compd; 2009; 13(6):525-30. PubMed ID: 23965326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality-control analytical methods: aqua pura: water purification systems and United States pharmacopeia waters for the compounding pharmacy, part 1.
    Latta KS; Cabaleiro J; Whitehead P; Edison D
    Int J Pharm Compd; 2011; 15(2):133-44. PubMed ID: 23696083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporating Quality Assurance in Pharmaceutical Compounding-related Courses in the PharmD Curricula.
    Hossain MF; Levesque D; Frye J; Rashid M
    Int J Pharm Compd; 2020; 24(4):322-326. PubMed ID: 32649305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality Assurance: Compounding Record Audits for Error Prevention.
    Hawkins J
    Int J Pharm Compd; 2023; 27(3):211-217. PubMed ID: 37267524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 15: personnel training, cleansing, and garbing.
    Okeke CC; Allen LV
    Int J Pharm Compd; 2009; 11(5):420-6. PubMed ID: 23966526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations.
    Allen LV
    Int J Pharm Compd; 2021; 25(6):491-496. PubMed ID: 34807845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical compounding or pharmaceutical manufacturing? A regulatory perspective.
    Timko RJ; Crooker PE
    Int J Pharm Compd; 2014; 18(2):101-11. PubMed ID: 24881112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating.
    Martin M
    Int J Pharm Compd; 2018; 22(4):303-312. PubMed ID: 30021186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.